Arcellx, Inc is a clinical-stage biotechnology company, which provides cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. The company was founded by David M. Hilbert and Luba Zaritskaya in December 2014 and is headquartered in Redwood City MD.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
209
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Arcellx Inc market cap is $6.73B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Arcellx Inc 52 week high is $115.13 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Arcellx Inc 52 week low is $53.07 as of November 22, 2026.
Arcellx Inc stock price today is $115.07.
Arcellx Inc stock price yesterday was $115.03.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Arcellx Inc's P/E ratio is -28.38.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Arcellx Inc P/B ratio is 16.5674.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Arcellx Inc 50-day moving average is $114.70.